Latest Financials News

Ansell Limited reports robust FY25 half-year results, driven by strong organic sales and EBIT growth, while accelerating its KBU integration and productivity initiatives.

Ansell Limited has delivered a robust first half for FY25, reporting a near 30% increase in revenue and a remarkable 183.5% jump in net profit, driven by strong segment growth and strategic acquisition integration.

Xstate Resources has divested its 25% stake in the Crest Jinn assets in Alberta, Canada, opting for a modest royalty interest as it refocuses amid geopolitical and operational uncertainties.

PM Capital Global Opportunities Fund has declared a 5.5 cent fully franked interim dividend for H1 FY25 and reaffirmed its commitment to an 11.0 cent annual dividend, supported by a 6.0% portfolio return for the year ending December 2024.

PM Capital Global Opportunities Fund Limited has announced a fully franked ordinary dividend of AUD 0.055 per security for the half-year ending December 2024, offering shareholders a Dividend Reinvestment Plan option.

PM Capital Global Opportunities Fund Limited reported an 11% rise in half-year profit to $39.8 million and declared a higher fully franked interim dividend of 5.5 cents per share, reflecting strong portfolio performance amid global market volatility.

Helios Energy Ltd has secured A$691,325 through interest-free Convertible Notes to advance its Presidio Project in Texas, ensuring regulatory compliance and operational continuity.

360 Capital Mortgage REIT has updated the market with the payment of a 5.2 cent per unit distribution for January 2025, marking its first under the Attribution Managed Investment Trust (AMIT) regime.

The Supreme Court of Western Australia has approved the merger between Horizon Minerals and Poseidon Nickel, setting the stage for a significant consolidation in the nickel sector. Key dates for trading suspension and scheme implementation have now been confirmed.

Citigroup Global Markets Australia has announced a fully franked dividend of AUD 1.10 for the REA Instalment MINI, with key dates set for early March 2025. This move aligns closely with the dividend schedule of the underlying REA Ordinary Security.

The Australian Office of Financial Management has issued a new 4.25% Treasury Bond due in 2036, set to begin trading on the ASX from February 13, 2025. This issuance adds a fresh long-term government debt instrument to the market.

Neuren Pharmaceuticals has received a significant cash inflow of approximately US$50 million following the sale of a Priority Review Voucher linked to its Rett syndrome treatment. This milestone underscores the growing value of Neuren’s neurological drug portfolio and its partnership with Acadia Pharmaceuticals.